Wednesday, November 11, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Markets

Market: Remedium prioritize global expansion

Fiinews by Fiinews
August 12, 2025
in Markets
Reading Time: 2 mins read
A A
0
Remedium Lifecare
0
SHARES
18
VIEWS
LinkedinShare on Twitter

Munjal focus on CDMO-R&D services

BSE-listed Remedium Lifecare of Mumbai is prioritizing global expansion, especially entering new international geographies and strengthening its presence in existing markets.

It is also executing a long-term growth plan aimed at expanding its research and development (R&D) focus across key therapeutic areas such as anti-infectives, cardiovascular, and central nervous system (CNS) treatments.

This initiative will strengthen its innovation pipeline and ensure the development of advanced healthcare solutions, said Adarsh Munjal, Managing Director of Remedium Lifecare https://fieo.org/.

“Our focus is to build a robust foundation for Contract Development and Manufacturing Organisation (CDMO) and R&D services that will position Remedium to secure new contracts, drive innovation, and improve margins through backward integration. Enhancing working capital will further improve inventory and supply chain management, ensuring seamless operations across its distribution network.

“These strategic initiatives, combined with its robust Q1 performance, will enable Remedium Lifecare to enhance operational resilience, drive innovation, and consolidate its leadership in both domestic and international markets,” he said on 11 Aug https://www.bseindia.com/.

Remedium reported a Profit After Tax (PAT) of Rs.464.88 lakhs for quarter ended 30 June 2025, a significant improvement from the loss of Rs.204.60 lakhs recorded in the previous quarter ended 31 March 2025.

A rapidly growing player in the pharmaceutical supply chain and specialty chemicals sector, the company said Q1 PAT has already surpassed the company’s total PAT for the entire FY25, which stood at Rs.212.94 lakhs, highlighting strong operational momentum and a sharp rebound in profitability.

Munjal said, “This quarter marks a significant milestone for Remedium Lifecare. Our focused strategy on operational efficiency and prudent financial management has resulted in a robust turnaround, with Q1 PAT surpassing the entire FY25 profit https://www.nseindia.com/.

“We remain committed to building on this momentum and delivering sustained value to our shareholders while driving growth in our core healthcare and pharmaceutical segments.” Founded in 1988, Remedium Lifecare Ltd is a pharmaceutical company engaged in the trading and distribution of raw material as a supply chain management for the pharmaceutical industry with an emphasis on quality, compliance, and global reach, the company continues to expand its presence while playing a pivotal role in India’s pharmaceutical ecosystem. Fiinews.com

Tags: Remedium Lifecare
ShareTweetShare

Related Posts

Jindal SAW
Markets

Market: Jindal expands in Abu Dhabi

by Fiinews
November 11, 2026
0
17

New facility aligns with the UAE’s ‘Make it in the Emirates’ and ‘We the UAE 2031’ vision programs Jindal SAW...

Screenshot
Markets

Market: Expansion for global growth – Infravision

by Fiinews
November 11, 2026
0
18

Pradeep Kumar focused on India’s grid demand and transmission construction at scale Infravision, a Noida headquartered company transforming how critical...

Alight

Market: India to be global delivery-capability hub

November 10, 2026
19
NSE

Market: EGR goes live on NSE

November 8, 2026
17
ServiceNow

Market: Partners to scale agentic AI for customers

November 6, 2026
16
Perma Pipe

Market: PPHI to provide IFBE coating to India

November 4, 2026
21
SBI YONO

Recent News

  • Manufacture: NTPC to make urea-DME from coal
  • Invest: Japanese keen in partnering with Indians
  • Market: Jindal expands in Abu Dhabi
  • Market: Expansion for global growth – Infravision
  • Project: Investors to get red carpet treatment

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.